以创新激励为导向的药品注册改革-基于上海市药品上市许可持有人制度的试点经验分析
Drug Registration Reform Guided by Innovation Incentives——Analysis of Pilot Experience Based on Shanghai Marketing Authorization Holder System
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |